Lifesci Capital analyst S. Slutsky anticipates that the company will post earnings of ($3.14) per share for the year. The consensus estimate for ABIVAX Société Anonyme’s current full-year ...

Aura Biosciences (NASDAQ:AURA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a ...

Insiders have been showing their love for these four biotech stocks, and one tech stock, lately with huge share purchases.

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- LifeSci Communications today announced key leadership appointments and promotions designed to support its continued growth and strengthen its service ...

In a report released on March 21, Bradley Canino from Stifel Nicolaus maintained a Buy rating on Pyxis Oncology (PYXS – Research Report), with ...

Brainomix, an Oxford-born company pioneering AI-powered imaging tools in stroke and lung fibrosis, has clinched an $18 ...

In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report), with a ...

LifeSci Capital has initiated coverage with an Outperform rating. Citigroup recently maintained its Buy rating, while H.C. Wainwright reiterated a Neutral rating. German clinical-stage ...